slider – We See Value That Others Cannot.

We See Value That Others Cannot.

Bespoke capital solutions for commercial-stage healthcare and life science companies and royalty owners

For Companies
Customize finance solutions

For Institutions
Unlock IP Value

For Inventors
Diversify Assets

Our Approach

We specialize in the Healthcare and Life Science sectors and tailor our solutions to preserve our partners’ ownership interests.

Clinical Data Review

Competitive Environment Review

Financial Modeling

Market Strategy Review

Industry Expert Consultation

IP Review

Case Studies

SWK has constructed a variety of financing structures to maximize operational flexibility and increase our partners’ equity value.

Case Study: Orametrix

Structured Credit

Read More »

Case Study: Opiant

Royalty

Read More »

Case Study: Innopran XL

Product Purchase

Read More »

Partner Testimonials

“SWK was a perfect partner at the perfect time. While bridging from a prior lender to an eventual sale of the company, SWK proved to be a fantastic partner and provided a solution tailored to our needs. I am not sure we could have orchestrated this transition effectively without SWK.”

– Jay Widdig, CFO of Orametrix

“While CEO of Galil Medical, we established a long and collaborative partnership with the SWK team. The SWK team was a strong and professional partner beginning with pre-term sheet diligence, through negotiating and closing on the deal, and right through to successfully selling Galil to a strategic acquirer. Along the way we actively and openly worked with the SWK team as we evaluated multiple strategic options for the company.”

– Marty Emerson, President & CEO of Monteris Medical (previously President & CEO of Galil Medical)

“SWK has been a great partner to SolSys Medical since we established our financing relationship in 2015. Through their thorough understanding of our business and the industry, SWK provided a flexible capital solution that grew with our business, facilitating our rapid growth and ultimate sale to Misonix.  The SWK investment team proved very thoughtful helping SolSys manage growing pains and are trusted business partners.”

– Allan Staley, CEO of Solsys Medical

Clients Served

Since inception SWK and partners have closed 34 transactions, funding nearly $500mm into the life science industry.

See more on our Portfolio Page »

Partner with SWK

We specialize in sub-$50M opportunities. Please provide us with your contact information for a consultation, or give us a call to learn more.